Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,787,679 papers from all fields of science
Search
Sign In
Create Free Account
Disease-Free Survival
Known as:
Survival, Disease Free
, Survivals, Disease-Free
, Survivals, Event-Free
Expand
The length of time after treatment for a specific disease during which a patient survives with no sign of the disease. Disease-free survival may be…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Progression-Free Survival
Remission Induction
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Five-Year Clinical Follow-Up After Intracoronary Radiation: Results of a Randomized Clinical Trial
M. Grise
,
V. Massullo
,
+9 authors
P. Teirstein
Circulation
2002
Corpus ID: 22315023
Background—Several clinical trials indicate that intracoronary radiation is safe and effective for treatment of restenotic…
Expand
Highly Cited
2000
Highly Cited
2000
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
P. Fenaux
,
S. Chevret
,
+19 authors
for the Gimema group
Leukemia
2000
Corpus ID: 6272650
First results of a randomized trial (APL91 trial) and other randomized or non-randomized studies have shown that ATRA followed by…
Expand
Highly Cited
1998
Highly Cited
1998
Serous borderline tumors of the ovary with noninvasive peritoneal implants
D. Gershenson
,
Elvio G. Silva
,
G. Tortolero-Luna
,
C. Levenback
,
M. Morris
,
C. Tornos
Cancer
1998
Corpus ID: 23782677
The authors conducted this study to update their experience with patients who have ovarian serous borderline tumors with…
Expand
Highly Cited
1996
Highly Cited
1996
Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.
Olivier Feugeas
,
N. Guriec
,
+10 authors
F. Oberling
Journal of Clinical Oncology
1996
Corpus ID: 2712923
PURPOSE The usual therapy of osteosarcoma is neoadjuvant chemotherapy, followed by surgery, then by postoperative chemotherapy…
Expand
Highly Cited
1995
Highly Cited
1995
Prognostic significance of pathologic features of hepatocellular carcinoma a multivariate analysis of 278 patients
I. Ng
,
E. Lai
,
S. Fan
,
M. Ng
,
Mike K. P. So
Cancer
1995
Corpus ID: 10073264
Background. In patients with hepatocellular carcinoma, surgical resection may offer a chance of cure. However, tumor recurrence…
Expand
Highly Cited
1995
Highly Cited
1995
Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update.
Mitchell S. Anscher
,
Cary N. Robertson
,
L. Prosnitz
International Journal of Radiation Oncology…
1995
Corpus ID: 25449072
Highly Cited
1993
Highly Cited
1993
Re-treatment of nasopharyngeal carcinoma in 53 patients.
R. Pryzant
,
C. Wendt
,
L. Delclos
,
L. Peters
International Journal of Radiation Oncology…
1993
Corpus ID: 20586841
Highly Cited
1991
Highly Cited
1991
Nitric oxide: mediator of nonadrenergic noncholinergic responses of opossum esophageal muscle.
J. Murray
,
C. Du
,
A. Ledlow
,
J. N. Bates
,
J. Conklin
American Journal of Physiology
1991
Corpus ID: 45320152
Nonadrenergic noncholinergic (NANC) nerves of the opossum esophagus mediate relaxation of circular muscle from the lower…
Expand
Highly Cited
1988
Highly Cited
1988
Inhibition of cholinergic neurotransmission in human airways by beta 2-adrenoceptors.
K. Rhoden
,
L. Meldrum
,
P. Barnes
Journal of applied physiology
1988
Corpus ID: 20283783
The purpose of the study was to determine whether catecholamines modulate cholinergic neurotransmission in isolated human airway…
Expand
Review
1981
Review
1981
Megavoltage irradiation of epithelial tumors of the nasopharynx.
J. Mesic
,
G. Fletcher
,
H. Goepfert
International Journal of Radiation Oncology…
1981
Corpus ID: 33972754
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE